Search all trials

Find therapies in clinical trials near you – page 9

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Crohn's disease

Recruiting

Investigational

Study on the Effects of Zasocitinib for Patients with Moderate to Severe Crohn's Disease

Investigational

Czechia

Participants:18–64 years · 65+ years
Substances:Zasocitinib

Contact Research Centre

Adenocarcinoma of colon

Recruiting

Registered drugNo placebo

Study of Dostarlimab and Drug Combination for Patients with Untreated Resectable Colon Cancer

Registered drugNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Capecitabine

Contact Research Centre

Generalised tonic-clonic seizure+1

Recruiting

InvestigationalNo placebo

Study on the Long-term Safety and Tolerability of Azetukalner for Patients with Epilepsy, Including Focal-onset and Primary Generalized Tonic-Clonic Seizures

InvestigationalNo placebo

Czechia

Participants:0–17 years · 18–64 years · 65+ years
Substances:Azetukalner

Contact Research Centre

Malignant melanoma

Recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of Lifileucel and Pembrolizumab for Patients with Untreated, Unresectable, or Metastatic Melanoma

Registered drugNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Aldesleukin

Contact Research Centre

Partial seizures

Recruiting

Investigational

Study on the Effects of Azetukalner in Patients with Focal-Onset Seizures

Investigational

Czechia

Participants:18–64 years · 65+ years
Substances:Azetukalner

Contact Research Centre

Cervix carcinoma

Recruiting

Registered drugNo placebo

Study on the Effects of Carboplatin and Cisplatin in Patients with Early-Stage, Intermediate-Risk Cervical Cancer

Registered drugNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Malignant lymphoid neoplasm

Recruiting

InvestigationalNo placebo

Long-Term Follow-Up Study for Patients Treated with Idecabtagene Vicleucel or Lisocabtagene Maraleucel for Cancer

InvestigationalNo placebo

Czechia

Participants:0–17 years · 18–64 years · 65+ years
Substances:CC-97540

Contact Research Centre

Crohn's disease

Recruiting

InvestigationalNo placebo

Study of Lutikizumab, ABBV-382, and Risankizumab for Adults with Moderate to Severe Crohn's Disease

InvestigationalNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:ABBV-8736

Contact Research Centre

Pancreatic carcinoma metastatic

Not yet recruiting

Registered drugNo placebo

Phase 3 Study of atebimetinib with gemcitabine and paclitaxel versus gemcitabine and paclitaxel in patients with metastatic pancreatic cancer

Registered drugNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Paclitaxel

Contact Research Centre

Type 2 diabetes mellitus

Not yet recruiting

Registered drugNo placebo

Study of zenagamtide versus insulin glargine in adults with type 2 diabetes and high cardiovascular risk uncontrolled on oral medications

Registered drugNo placebo

Czechia

Participants:18–64 years
Substances:Insulin Glargine

Contact Research Centre

Arteriosclerosis

Not yet recruiting

Investigational

A study to evaluate the effect of muvalaplin on reducing major cardiovascular events in adults with high levels of lipoprotein(a) and atherosclerotic cardiovascular disease.

Investigational

Czechia

Participants:18–64 years · 65+ years

Contact Research Centre

Arteriosclerosis

Not yet recruiting

Investigational

Study of Olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)

Investigational

Czechia

Participants:18–64 years · 65+ years

Contact Research Centre

Find therapies in clinical trials near you – page 9

190 trials match your criteria

Crohn's disease

Study on the Effects of Zasocitinib for Patients with Moderate to Severe Crohn's Disease

Adenocarcinoma of colon

Study of Dostarlimab and Drug Combination for Patients with Untreated Resectable Colon Cancer

Generalised tonic-clonic seizure+1

Study on the Long-term Safety and Tolerability of Azetukalner for Patients with Epilepsy, Including Focal-onset and Primary Generalized Tonic-Clonic Seizures

Malignant melanoma

Study on the Effectiveness and Safety of Lifileucel and Pembrolizumab for Patients with Untreated, Unresectable, or Metastatic Melanoma

Partial seizures

Study on the Effects of Azetukalner in Patients with Focal-Onset Seizures

Cervix carcinoma

Study on the Effects of Carboplatin and Cisplatin in Patients with Early-Stage, Intermediate-Risk Cervical Cancer

Malignant lymphoid neoplasm

Long-Term Follow-Up Study for Patients Treated with Idecabtagene Vicleucel or Lisocabtagene Maraleucel for Cancer

Crohn's disease

Study of Lutikizumab, ABBV-382, and Risankizumab for Adults with Moderate to Severe Crohn's Disease

Pancreatic carcinoma metastatic

Phase 3 Study of atebimetinib with gemcitabine and paclitaxel versus gemcitabine and paclitaxel in patients with metastatic pancreatic cancer

Type 2 diabetes mellitus

Study of zenagamtide versus insulin glargine in adults with type 2 diabetes and high cardiovascular risk uncontrolled on oral medications

Arteriosclerosis

A study to evaluate the effect of muvalaplin on reducing major cardiovascular events in adults with high levels of lipoprotein(a) and atherosclerotic cardiovascular disease.

Arteriosclerosis

Study of Olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.